Lasmiditan Succinate Patent Expiration

Lasmiditan Succinate is Used for managing acute migraine attacks. It was first introduced by Eli Lilly And Co in its drug Reyvow on Jan 31, 2020.


Lasmiditan Succinate Patents

Given below is the list of patents protecting Lasmiditan Succinate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Reyvow US11053214 Compositions and methods related to pyridinoylpiperidine 5-HT1F agonists Dec 05, 2037 Eli Lilly And Co
Reyvow US7423050 Pyridinoylpiperidines as 5-HT1F agonists Feb 17, 2028 Eli Lilly And Co
Reyvow US8748459 Pyridinoylpiperidines as 5-HT1F agonists Mar 27, 2023

(Expired)

Eli Lilly And Co


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lasmiditan Succinate's patents.

Given below is the list recent legal activities going on the following patents of Lasmiditan Succinate.

Event Date Patent/Publication
Patent litigations
Patent Term Extension Certificate 11 Aug, 2023 US7423050
Electronic Review 16 May, 2023 US7423050
FDA Final Eligibility Letter 26 Apr, 2023 US7423050
PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED 19 Apr, 2023 US7423050
Interim Patent Term Extension Granted 27 Mar, 2023 US7423050
Terminal Disclaimer Filed 27 Mar, 2023 US7423050
PTE Interim Patent Extension filed 23 Mar, 2023 US7423050
transaction for FDA Determination of Regulatory Review Period 13 Sep, 2022 US7423050
Letter from FDA or Dept of Agriculture re PTE application 08 Sep, 2022 US7423050
Payment of Maintenance Fee, 8th Year, Large Entity 17 Nov, 2021 US8748459



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳